TOKYO (Reuters) – A Japanese Health Ministry committee has approved the oral COVID-19 drug made by U.S. drugmaker Pfizer Inc, the ministry said in a statement on Friday.
Jiji news agency said final approval of the drug for use, which officials had said they expected would come around mid-February, could come as early as Friday night under emergency approval measures.
Pfizer applied for approval in January.
(Reporting by Elaine Lies; Editing by Catherine Evans)
